Cullivan Julie A 4
Research Summary
AI-generated summary
Heartflow Director Julie Cullivan Receives 16,075-Share Award
What Happened
Julie A. Cullivan, a director of Heartflow, Inc. (HTFL), was granted a derivative equity award for 16,075 shares with a price of $32.05 per share, representing a total grant value of $515,204. This was an award/grant transaction (derivative), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-16; filing date: 2026-06-18 (timely filed within Form 4 rules).
- Instrument: derivative equity award at $32.05 per share; reported total value $515,204.
- Shares reported in grant: 16,075.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnote: The award vests in full on the earlier of the day before Heartflow's 2027 annual meeting and the first anniversary of the grant date, subject to continued service.
- Transaction code: A (award/grant).
Context
This filing reports a grant of an equity-based derivative (e.g., option or similar award) to a board member; the award is subject to vesting and was not exercised or sold. Such grants are common as director compensation and align long-term incentives with shareholders but are not the same signal as an insider buying shares in the open market.